classified patients with CRS treated with TNF‐α inhibitors into a separate subtype and also found that CRS on TNF‐α inhibitors (TNFαis) significantly reduced the number of eosinophils when compared to patients with CRSwNP. The gene discussed is TNF; the disease is chronic rhinosinusitis with nasal polyps.